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ABSTRACT 
Aim: A study on effectiveness and success factors of educational inhaler technique intervention in asthma and COPD. 
Objectives: To identify the percentage of common errors done by people who use inhalers. To identify the risk factors associated 
with asthma and COPD. 
Method: Data was collected from the subject’s face to face interview in a community setup and the lung capacities were measured using 
spirometer and peak flow meter; the values were noted and the subjects were asked to demonstrate their inhaler technique using 
placebo inhalers; numbers of correct and incorrect steps were noted. After a period of one month; the subjects were taken to follow up 
and measured the lung capacities and checked the inhaler steps; number of correct and incorrect steps were noted. 
Results: A total of 572 samples were collected and 500 were followed up, in which 300 had Asthma and 200 had COPD. Out of which 189 
were female and 311 were male. Low education level was the single most important factor leading to incorrect technique. Formal training 
resulted in a statistically significant increase in the percentage of correct techniques for all the devices. For pMDI (54.01% vs. 91.03%, 
*p=0.005 before & after training respectively). For pMDI+Spacer (52.75% vs. 94.85%, *p=0.007 before & after training 
respectively). For Accuhaler (54.07% vs. 91.27%, *p=0.017 before & after training respectively). For Rotahaler (63.94 vs. 
98.64%. *p=0.029 before & after training respectively). For Nebuliser (56.97% vs. 91.88%, *p=0.001 before & after 
training respectively.  
Conclusion: Proper education to patients on correct usage may not only improve control of the symptoms of the disease but might also 
allow dose reduction in long term. The number of subjects doing correct steps gradually increased after the pharmacist led 
intervention. Thus, proper counselling for the inhaler use in patients must be encouraged as it is directly linked to the quality of life of 
patient.  
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INTRODUCTION 
Chronic respiratory diseases are a group of chronic 
diseases affecting the airways and the other structures of 
the lungs. common chronic respiratory diseases are asthma, 
bronchiectasis, chronic obstructive lung disease, including 
chronic obstructive pulmonary disease, bronchitis and 
emphysema, chronic rhinosinusitis, hypersensitivity 
pneumonitis, lung cancer and neoplasms of respiratory 
and intrathoracic organs, lung fibrosis, chronic 
pleural diseases, pneumoconiosis, pulmonary 
eosinophilia, pulmonary heart disease and diseases of 
pulmonary circulation including pulmonary embolism, 
pulmonary hypertension and corpulmonale, rhinitis, 
sarcoidosis, sleep apnoea syndrome1,2. 
Asthma 
Asthma is a chronic inflammatory disorder due to 
inflammation of the air passages in the lungs and affects 
the sensitivity of the nerve endings in the airways so they 
become easily irritated. In an attack, the lining of the 
passages swell causing the airways to narrow and 
reducing the flow of air in and out of the lungs3,4. 
COPD 
Chronic obstructive pulmonary disease (COPD) is a lung 
disease characterized by chronic obstruction of lung 
airflow that interferes with normal breathing and is 
not fully reversible. The more familiar terms 'chronic 
bronchitis' and 'emphysema' are no longer used, but are 
Bhavana et al                                                                                                           Journal of Drug Delivery & Therapeutics. 2019; 9(2):170-179 
ISSN: 2250-1177                                                                                  [171]                                                                                 CODEN (USA): JDDTAO 
now included within the COPD diagnosis. COPD is not 
simply a "smoker's cough" but an under-diagnosed, life-
threatening lung disease5,6. 
A COPD diagnosis is confirmed by a simple test called 
spirometry, which measures how deeply a person can 
breathe and how fast air can move into and out of the 
lungs. Such a diagnosis should be considered in any 
patient who has symptoms of cough, sputum 
production, or dyspnoea (difficult or labored breathing), 
and/or a history of exposure to risk factors for the 
disease6-8. 
Aim 
To study on effectiveness and progress outcomes of 
educational inhaler technique intervention in asthma and 
COPD patients. 
Objectives 
 To identify the percentage of common errors done by 
people who use inhales. 
 To identify the risk factors associated with asthma and 
COPD. 
 To identify the type of inhalers and medications used by 
patients. 
 Educating and training correct inhalation 
techniques to achieve the optimal therapeutic 
benefit. 
 To conduct the patient counselling and assess the 
knowledge gained and to improve patient quality of 
life. 
MATERIALS AND METHODS 
Study site: 
In and around areas of south parts (Hanumanth nagar, 
Jayanagar) of Bengaluru, Karnataka, India. 
Study design: 
This is a prospective, community based study. 
Study period: 
The study was carried out for a period of six months. 
Study criteria: 
Inclusion criteria 
 All patients who are diagnosed with asthma and COPD 
 Patients who use inhalers 
 Age 5-85 years’ old 
 Both the gender 
 Different educational status 
 Patients who are willing to give consent 
Exclusion criteria 
 Patients who are not using inhalers are excluded 
 Patients having other respiratory problems (bronchitis, 
pneumonia etc.) other than asthma and COPD are 
excluded. 
Materials used 
1. Peak Expiratory Flow meter 
2. Three ball incentive spirometer 
Peak expiratory flow meter 
The Peak Flow Meter here used was Wright’s Peak Flow 
Meter. The peak expiratory flow (PEF), also called peak 
expiratory flow rate (PEFR) is a person's maximum speed of 
expiration, as measured with a peak flow meter, a small, 
hand-held device used to monitor a person's ability to 
breathe out air. It measures the airflow through the bronchi 
and thus the degree of obstruction in the airways. Peak 
expiratory flow is typically measured in units of litres per 
minute (L/min). 
Three ball incentive spirometers 
The incentive spirometer here used was Romsons 
Respirometer. 
Study procedure 
The participants who attended the camp with their 
prescriptions which was been printed in the pamphlets, 
which was distributed the previous day were given with the 
complete information about our study. The interested 
subjects were given with the informed consent form. After 
taking the consent, in the local vulnerable language and the 
patient was made to rest for five minutes, in this time, the 
patient details such as demographic details, whether they 
have asthma or COPD, family history, smoking status, 
allergies, symptoms, comorbidities, medications etc. Then we 
ask them to perform the spirometer for 3 times will take the 
average of two readings and followed by peak flow meter 
will note the readings. Then we will ask the patients what 
kind of inhalers they are using and ask them to demonstrate 
the inhaler use and will note the steps how they are using. 
After their demonstration, we will educate the patients about 
correct inhaler techniques followed by life style modification. 
After certain period (1month) we will follow the same 
procedure within the same subjects and we have compared 
the results. The data was analysed using suitable statistical 
methods to assess the correct inhaler techniques. 
Statistical analysis 
The data collected was transferred and analysed using SPSS 
Software version 24. Descriptive statistics, such as the mean 
and standard deviations, were used to summarize the 
quantitative variables. The percentage and numbers were 
used to summarize categorical variables. Chi square test 
was used for the measurement of spirometer and one way 
ANOVA and was used for the measurement of peak flow 
meter to test the association between lung capacities across 
the good inhaler technique. Paired T- test were used to 
measure the inhaler techniques. All the analysis was done 
using SPSS version 24. All the analysis was considered 
statistically significant at 5% level (p-value<0.05). 
RESULTS 
A prospective community based study was conducted over 
a period of 6 months in and around areas of south parts 
(Hanumanth Nagar, Jayanagar) of Bengaluru, Karnataka. 
During the study 572 patients with asthma and COPD 
were enrolled and 500 patients were followed up. 
Table 1: Gender distribution 
Gender No. of subjects 
Female 189 (37.8%) 
Male 311 (62.2%) 
Total 500 (100%) 
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Table 2: Distribution of patients according to age group 
Age category Male Female No. of subjects 
 
0-19 
 
5 (1.6%) 
 
5 (2.6%) 
 
10 (2%) 
 
20-29 
 
29 (9.3%) 
 
31 (16.4%) 
 
60 (12%) 
 
30-39 
 
64 (20.5%) 
 
41 (21.6%) 
 
105 (21%) 
 
40-49 
 
73 (23.4%) 
 
40 (21.16%) 
 
113 (22.6%) 
 
50-59 
 
58 (18.6%) 
 
38 (20.1%) 
 
96 (19.2%) 
 
60-69 
 
48 (15.4%) 
 
26 (13.7%) 
 
74 (14.8%) 
 
70-79 
 
27 (8.6%) 
 
6 (3.1%) 
 
33 (6.6%) 
 
80-89 
 
7 (2.2%) 
 
2 (1.0%) 
 
9(1.8%) 
 
Total (N) = 
 
311(100%) 
 
189 (100%) 
 
500 (100%) 
 
 
Figure 1: Distribution according to age (in years) group 
 
Out of 500 subjects enrolled, the overall age group of 
subjects ranged from 10-90 years old. In 40-49yrs of age 
group 113(22.6%) patients were both asthma and COPD, 
whereas in 30-39 there were 105(21%), then in 50-59 there 
were 96(19.2%), then in 60-69 there were 74(14.8%), then 
20-29 there were 60(12%), then in 70-79 there were 
33(6.6%) and in 10-19 there were 10(2%) asthma and COPD 
subjects, then least was found in 80-89 age there were 
9(1.8%) of subjects. Most of the patients were between the 
age range from 40-49 years in both asthma and COPD. 
 
Table 3: Number of subjects based on asthma and COPD 
 
Condition 
 
No. of subjects (%) 
 
Asthma 
 
300 (60%) 
 
COPD 
 
200 (40%) 
 
Total 
 
500 (100%) 
 
Table 4: Gender distribution based on asthma and COPD 
 
Gender 
 
Asthma 
 
COPD 
 
Male 
 
130 (43%) 
 
183 (92%) 
 
Female 
 
170 (57%) 
 
17 (9%) 
 
Total (N=500) 
 
300 (100%) 
 
200 (100%) 
 
Table 5: Grouping subjects based on spirometry (Three 
ball test) before and after follow up 
Spirometry Before follow up After follow up 
Poor 245(49%) 62(12.4%) 
Average 203(40.6%) 281(56.2%) 
Good 52(10.45%) 157(31.4%) 
Total 500(100%) 500(100%) 
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Figure 2: Percentage of subjects based on spirometer 
 
Out of 500 subjects; 245 (49%) subjects had poor 
inspiratory lung capacity, 203(40.6%) subjects had average 
inspiratory lung capacity, and 52 (10.4%) subjects had good 
inspiratory lung capacity. After a period of one month 
62(12.4%) had poor inspiratory lung capacity, 281(56.2%) 
had average inspiratory lung capacity, 157(31.4%) has good 
inspiratory lung capacity. 
 
 
Figure 3: Percentage of subjects based on peak flow meter 
 
Out of 500 subjects; 386 (77.2%) subjects had poor 
expiratory lung capacity, 111(22.2%) subjects had average 
expiratory lung capacity,3(0.6%) subjects had good 
expiratory lung capacity. After a period of one month 
66(13.2%) had poor expiratory lung capacity, 358(71.6%) 
had average expiratory lung capacity,76(15.2%) has good 
expiratory lung capacity. 
 
Table 6: Reported risk factors for asthma and COPD 
Factors Asthma COPD 
Allergies (pollens, house dust mites, cooking) 146 (48.6%) 0 
Smoking 16 (5.3%) 116 (58%) 
Family history 83 (27.6%) 22 (11%) 
Air pollution 48 (16%) 44 (22%). 
Occupational exposure 7 (2.33%) 18 (9%) 
Total 300 (100%) 200 (100%) 
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Figure 4: Percentage of risk factors for asthma and COPD 
 
Out of 300 subjects of asthma 146 (48.6%) were exposed to 
allergies, 16 (5.33%) were exposed to smoking, 83 (27.6%) 
were exposed to family history, 48 (16%) were exposed to 
air pollution, 7 (2.33%) were exposed to occupational 
exposure. The population of asthmatic patients 146 (48.6%) 
having allergy. 
Out of 200 subjects of COPD 116 (58%) were exposed to 
smoking, tobacco, 44 (22%) were exposed to alcohol, 22 
(11%) were exposed to air pollution, 48 (16%), 18 (9%) 
were exposed to occupational exposure. There was higher 
number of Patients diagnosed with COPD who had smoking 
habit 116 (58%) than patients diagnosed with asthma 16 
(5.33%).  
Table 7: Signs and symptoms of COPD 
Signs and symptoms No. of subjects 
Shortness of breath, wheezing, chest 
tightness 
57 (28.5%) 
Cough, cough with sputum 94 (47%) 
Respiratory infections 18 (9%) 
Weight loss/ weakness 31 (15.5%) 
Total 200 (100%) 
 
The major symptoms presented by COPD patients were 
found to be cough, cough with sputum (47%), shortness of 
breath, wheezing, chest tightness (28.5%), weight loss or 
weakness (15.5%), respiratory infection (9%). 
Table 8: Signs and symptoms of asthma 
Signs and symptoms Number of subjects 
Chest tightness, wheezing, 
difficulty breathing 
176 (58.6%) 
Cough 116 (38.7%) 
Respirator/throat infections 8 (2.7%) 
Total (N)= 300 (100%) 
 
In our study, the major symptoms presented by the asthma 
patients were found to be chest tightness, wheezing, 
difficulty in breathing (58.6%), cough (38.7%), respiratory 
or throat infections (8.27%). Most commonly seen sign 
&symptom were cough in COPD patients and chest tightness, 
wheezing, difficulty in breathing in asthma patients. Least 
commonly seen was respiratory/throat infections in both. 
Table 9: Types of inhalers used 
Inhaler device No. of subjects 
pMDI 168 (33.6%) 
pMDI + Spacer 49 (9.8%) 
Rotahaler 98 (19.6%) 
Accuhaler 118 (23.6%) 
Nebulise 68 (13.6%) 
Total (N)= 500 (100%) 
 
 
Figure 5: Percentage of different types of inhalers used 
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Out of 500 patients of asthma and COPD 168 (33.60%) were 
using PMDI whereas 49 (9.8%) were using PMDI+SPACER; 
98 (19.6%) were using rotahaler, 117 (23.6%) were using 
accuhaler, 68 (13.6%) were using nebuliser. 
 
 
Figure 6: Percentage of subjects with correct inhaler technique 
 
Our study confirms a significant increase in percentage of 
improvement in inhalation technique after face to face 
demonstrations and training. Although the inhalation 
technique significantly improved among pMDI, 
pMDI+Spacer, accuhaler, rotahaler, nebulizer. These results 
suggest that patients should bring all their inhalers to each 
visit, and should be able to demonstrate their correct use. All 
patients need face to face training and retraining for 
successful inhaler use. 
 
 
Figure 7: pMDI (% of subjects doing correct steps before and after follow up) 
 
In PMDI the most common error done by the patient was 
shake the inhaler, continue slow and deep inhalation and 
hold breath for 5-10 sec before face to face training. After 
educating and demonstrating the good inhaler technique 
they gradually increased the correct use of inhaler and have 
been show to improve symptoms. Hence the *p value = 0.005 
hence it is statistically significant. 
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Figure 8: pMDI + Spacer (% of subjects doing correct steps before and after follow up) 
 
In pMDI+spacer the most common error done by the patient 
was take 5 to 10 slow breaths in and out through the mouth, 
do not remove the spacer from the mouth between breaths, 
breath out gently, shake the inhalers before face to face 
training. After educating and demonstrating the good inhaler 
technique they gradually increased the correct use of inhaler 
and have been show to improve symptoms. The study which 
is like Linda Bryant of adequacy of inhaler technique used by 
people with asthma and COPD, shows that 58% of 
participants using a pMDI+spacer were over 60yrs of age, 
indicating that medical practitioners are appropriately 
selecting inhaler devices for this group. Hence the *p value 
=0.007, so it is statistically significant. 
 
 
Figure 9: Accuhaler (% of subjects doing correct steps before and after follow up) 
 
In accuhaler the most common error done by the patient was 
not holding the breath for 5 to 10 sec, and not exhaling away 
from the mouth, exhales. After educating and demonstrating 
the good inhaler technique they gradually increased the 
correct use of inhaler and have been show to improve 
symptoms. Hence the *p value =0.017, so it is statistically 
significant.
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Figure 10: Dry powder inhaler (% of subjects doing correct steps before and after follow up) 
 
In rotahaler the most common error done by the patient was 
not holding the breath for 5 to 10 sec, and not exhaling, not 
tilting head back a little, not breathing out gently, not 
inhaling quickly and deeply through mouth before face to 
face training. After educating and demonstrating the good 
inhaler technique they gradually increased the correct use of 
inhaler and have been show to improve symptoms. Hence 
the *p value =0.029, so it is statistically significant. 
 
 
Figure 11: Nebuliser (% of subjects doing correct steps before and after follow up) 
 
In nebulizer, the most common error done by the patient 
was not repeating steps 4-6 until a cloud is visible, then not 
repeating three more times before use; before face to face 
training. After educating and demonstrating the good inhaler 
technique they gradually increased the correct use of inhaler 
and have been show to improve symptoms. Hence the *p 
value =0. 001. Hence it is statistically significant. 
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Table 10: Number of subjects who took mono therapy 
Medications No. of subjects 
Asthalin 40 (36%) 
Ipratropium bromide 30 (27.02%) 
Fluticasone proprionate 26 (23.40%) 
Budesonide 15 (13.51%) 
 
Out of 500 subjects 111patients were used monotherapy in 
which asthalin was the most commonly used drug followed 
by ipratropium bromide was the least drug. 
Table 11: Combination therapy: 267 
Medications No. of subjects 
Levosalbutamol + 
ipratropium bromide 
98 (36.70%) 
Beclomethasonl+ 
levosalbutamol 
74 (27.70%) 
Fluticasone + valanterol 40 (14.90%) 
Fluticasone + fprmeterol 36 (13.40%) 
Formeterol + budesonide 11 (4.11%) 
Salmeterol + fluticasone 19 (7.11%) 
 
 
Figure 12: Percentage of subjects who took Combination Therapy 
 
Out of 500 subjects 267 were used combination therapy 
levosalbutamol + ipratropium bromide was the most 
commonly used drugs. 
DISCUSSION 
During the study 572 patients with asthma and COPD were 
enrolled and only 500 were followed up. The total number 
of subjects enrolled in this study was 572 and the follow 
up obtained for 500 subjects out of which; 300 subjects 
had asthma and 200 subjects had COPD, out of which 
311 (62.2%) were male and189 (37.8%) were female, as 
represented in above graph. Out of 300 asthma subjects 
170 (56.6%) female population were affected by 
asthma, 130 (43.3%) male population were affected by 
asthma. whereas out of 200 COPD subjects 17 (8.5%) 
female population were affected by COPD and 183 (91.5%) 
were male population were affected by COPD. The overall 
age group of subjects ranged from 10-90 years old. The 
most of the patients were between the age ranges from 
40-49 years i.e. 113 patients (22.6%) in both asthma and 
COPD. The least was found in 80-89 age i.e. 9 (1.8%) of 
patients. 
Out of 500 subjects; 245 (49%) subjects had poor 
inspiratory lung capacity, 203 (40.6%) subjects had 
average inspiratory lung capacity, and 52 (10.4%) subjects 
had good inspiratory lung capacity. After a period of one 
month 62(12.4%) had poor inspiratory lung capacity, 
281(56.2%) had average inspiratory lung capacity, 
157(31.4%) has good inspiratory lung capacity. We have 
measured the lung capacities of subjects (inspiratory flow 
volume and expiratory flow volume) by using spirometer 
(3ball test) before and after the follow up. In spirometer, 
we have compared the results of the subjects before and 
after follow up (1 month) calculated p value using chi 
square test. Formal training of inhaler technique resulted 
in statistically significant increase in the inspiratory lung 
capacity before educating about inhaler use most of them 
had poor inspiratory lung capacity. After educating 
about correct technique of inhaler, which gradually 
increased their inspiratory lung capacity. Hence *p=0.00 
which shows that the results were statistically significant. 
Hence there is an association between good inhaler 
technique and lung capacity. In peak flow meter test, we 
have compared the results of the subjects before and after 
follow up (1month) we have calculated the p value using 
one way Anova test. Formal training of inhaler technique 
resulted in statistically significant increase in the expiratory 
lung capacity. Out of 500 subjects; 386 (77.2%) subjects 
had poor expiratory lung capacity, 111(22.2%) subjects 
had average expiratory lung capacity, 3 (0.6%) subjects 
had good expiratory lung capacity. 
After a period of one month 66(13.2%) had poor 
expiratory lung capacity, 358 (71.6%) had average 
expiratory lung capacity, 76 (15.2%) has good 
expiratory lung capacity. Before educating about inhaler 
use most of them had poor expiratory lung capacity. After 
educating about correct technique of inhaler which 
gradually increased their expiratory lung capacity. Hence 
p=0.00 which shows that the results were statistically 
significant. Hence there is an association between good 
inhaler technique and lung capacity. Out of 300 subjects 
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of asthma, 146 (48.6%) were exposed to allergies, 16 
(5.33%) were exposed to smoking, 83 (27.6%) were 
exposed to family history, 48 (16%) were exposed to air 
pollution, 7 (2.33%) were exposed to occupational exposure. 
Increase in allergy (pollens, house dust mite, cooking 
fuels) is Associated with increased severity in asthma. 
Exposure to smoke while performing domestic work 
presents a greater risk of development of asthma and 
COPD than other fuels. The number of people who used L.P 
gas was found to be higher than other types of cooking 
systems in a study mixed fuel users were also found to 
experience more respiratory problems. 
In pMDI+spacer the most common error done by the 
patient was not taking 5 to 10 slow breaths in and out 
through the mouth, and failure to remove the spacer 
from the mouth between breaths and breath out gently, 
also observed not shaking the inhalers before face to face 
training. After educating and demonstrating the good 
inhaler technique they gradually increased to use of 
inhaler technique correctly and has been showed to 
improve symptoms. The study which is similar to Linda 
Bryant of adequacy of inhaler technique used by people 
with asthma and COPD shows that 58% of participants 
using a PMDI+spacer were over 60yrs of age, indicating 
that medical practitioners are appropriately selecting 
inhaler devices for this group. Hence the *P value =0.007 
hence it is statistically significant. In accuhaler the most 
common error done by the patient was not holding the 
breath for 5 to 10 sec, and not exhaling away from the 
mouth, exhales. After educating and demonstrating the 
good inhaler technique they gradually increased the 
correct use of inhaler and have been show to improve 
symptoms. Hence the *P value =0.017 hence it is statistically 
significant. In rotahaler the most common error done by 
the patient was not holding the breath for 5 to 10 sec, and 
not exhaling, not tilting head back a little and breathing out 
gently, not inhaling quickly and deeply through mouth 
before face to face training. After educating and 
demonstrating the good inhaler technique they gradually 
increased the correct use of inhaler and have been 
shown to improve symptoms. Hence the *p value = 
0.029 hence it is statistically significant. 
In nebulizer, the most common error done by the patient 
was not repeating steps 4-6 until a cloud is visible, then not 
repeating three more times before use; before face to face 
training. After educating and demonstrating the good 
inhaler technique they gradually increased the correct use 
of inhaler and have been show to improve symptoms. 
Hence the *p value =0. 001. Hence it is statistically 
significant. Out of 500 subjects 111 patients were used 
monotherapy in which asthalin was the most commonly 
used drug followed by ipratropium bromide was the least 
drug. Out of 500 subjects 267 were used 
combination therapy levosalbutamol + ipratropium 
bromide was the most commonly used drugs. 
CONCLUSION 
The present study demonstrated that majority of patients 
with asthma and COPD were using incorrect inhaler 
techniques which is associated with poor disease 
control. That may be solved or prevented by pharmacist 
interventions. Our study showed that a high proportion 
(56%) of the participants had poor inhaler technique before 
counselling. which is consistent with the findings. Formal 
training resulted in a statistically significant increase in 
the percentage of correct techniques for all the 
devices. For pMDI (54.01% vs. 91.03%, *p=0.005 
before & after training respectively). For pMDI+Spacer 
(52.75% vs. 94.85%, *p=0.007 before & after training 
respectively). For Accuhaler (54.07% vs. 91.27%, 
*p=0.017 before & after training respectively). For 
Rotahaler (63.94 vs. 98.64%. *p=0.029 before & after 
training respectively). For Nebuliser (56.97% vs. 91.88%, 
*p=0.001 before & after training respectively). The results 
were statistically significant. 
The number of subjects doing correct steps gradually 
increased after the pharmacist led intervention. The most 
commonly used device was pMDI followed by DPIs, 
pMDI+Spacer, Nebuliser. So, review of the patient’s 
inhaler technique by clinical pharmacist can positively 
influence the patient’s outcomes and quality of life. In the 
present study majority of the patients with incorrect inhaler 
techniques were identified and counselled accordingly there 
by improved patient’s outcomes and quality of life. pMDI 
inhaler was the most common inhaler device used. The 
most common error for all devices was failure to exhale 
adequately before administering the dose. This improper 
technique is associated with poor Asthma and COPD 
control. Educational intervention on inhaler technique in 
Asthma and COPD patients are effective on the short term. 
Key predictors for success are patient’s initial 
technique and time elapsed since intervention. Hence 
pharmacist led intervention has the potential to improve 
patient inhaler technique compliance in control of asthma 
and COPD. 
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